Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSHARES TRUST (IBTA) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Ibotta (IBTA) over the last 3 years, with Q3 2025 value amounting to $1.5 million.

  • Ibotta's Other Accumulated Expenses fell 5703.56% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 5703.56%. This contributed to the annual value of $6.1 million for FY2024, which is 4102.39% up from last year.
  • Latest data reveals that Ibotta reported Other Accumulated Expenses of $1.5 million as of Q3 2025, which was down 5703.56% from $4.8 million recorded in Q2 2025.
  • In the past 5 years, Ibotta's Other Accumulated Expenses registered a high of $6.1 million during Q4 2024, and its lowest value of $1.5 million during Q3 2025.
  • For the 3-year period, Ibotta's Other Accumulated Expenses averaged around $4.2 million, with its median value being $4.1 million (2023).
  • Per our database at Business Quant, Ibotta's Other Accumulated Expenses surged by 4102.39% in 2024 and then crashed by 5703.56% in 2025.
  • Ibotta's Other Accumulated Expenses (Quarter) stood at $4.3 million in 2023, then surged by 41.02% to $6.1 million in 2024, then crashed by 74.62% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $4.8 million for Q2 2025, and $5.5 million during Q1 2025.